Cas:234082-00-9 14-tert-butoxy-14-oxo-tetradecanoic acid manufacturer & supplier

Chemical Name:14-tert-butoxy-14-oxo-tetradecanoic acid

CAS.NO:234082-00-9

Synonyms:Decanethylenediamine;1,12-dodecamethylenediamine;1,12-dodecanedicarboxylic acid mono-tert-butyl ester;1,12-DIAMINODODECANE;1,12-DODECANEDIAME;dodecyldiamine;Diaminododecane;1,12-diaminododecyl;Dodecane-1,12-diamine;Dodecamethylendiamin;DODECANEDIAMINE;1,12-dodecadiamine;RARECHEM AL BW 0116

Molecular Formula:C₁₈H₃₄O₄

Molecular Weight:314.46000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:63.60000

Exact Mass:314.24600

LogP:5.09390

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Decanethylenediamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,RARECHEM AL BW 0116 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,12-diaminododecyl Use and application,RARECHEM AL BW 0116 technical grade,usp/ep/jp grade.

Related News: The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed. 14-tert-butoxy-14-oxo-tetradecanoic acid manufacturer From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats. 14-tert-butoxy-14-oxo-tetradecanoic acid supplier In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers. 14-tert-butoxy-14-oxo-tetradecanoic acid vendor Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined. 14-tert-butoxy-14-oxo-tetradecanoic acid factory The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed.